Inmune Bio, Inc. Files 2024 Annual Report
Ticker: INMB · Form: 10-K · Filed: Mar 27, 2025 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 10-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, biotech, sec-filing
Related Tickers: INMB
TL;DR
INMB filed its 2024 10-K. Check financials and risks.
AI Summary
Inmune Bio, Inc. filed its 10-K for the fiscal year ended December 31, 2024, reporting on its operations as a biotechnology company focused on biological products. The company is incorporated in Nevada and its principal executive offices are located in Boca Raton, Florida. The filing details its financial performance and business operations for the year.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Inmune Bio's financial health, strategic direction, and potential risks for the fiscal year 2024.
Risk Assessment
Risk Level: medium — Biotechnology companies often face high risks due to the nature of drug development, regulatory hurdles, and market competition.
Key Numbers
- 001-38793 — SEC File Number (Identifies the company's filings with the SEC.)
- 47-5205835 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- December 31, 2024 (date) — Fiscal year end
- 20250327 (date) — Filing date
- Nevada (jurisdiction) — State of incorporation
- Boca Raton, FL (location) — Principal executive offices
- INMB (ticker) — Trading symbol
FAQ
What is the primary business of Inmune Bio, Inc.?
Inmune Bio, Inc. is engaged in the business of biological products, specifically excluding diagnostic substances, as indicated by its SIC code [2836].
When did Inmune Bio, Inc. file its 2024 annual report?
Inmune Bio, Inc. filed its 10-K for the fiscal year ended December 31, 2024, on March 27, 2025.
Where are Inmune Bio, Inc.'s principal executive offices located?
The principal executive offices of Inmune Bio, Inc. are located at 225 NE Mizner Blvd, Suite 640, Boca Raton, FL 33432.
What is the trading symbol for Inmune Bio, Inc.'s common stock?
The trading symbol for Inmune Bio, Inc.'s common stock is INMB.
In which U.S. state is Inmune Bio, Inc. incorporated?
Inmune Bio, Inc. is incorporated in the state of Nevada.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding Inmune Bio, Inc. (INMB).